Wordt geladen...
Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9
The anticancer properties of epigallocatechin-3-gallate (EGCG) are documented in the treatment of several types of cancer; however, there is no relevant evidence for its efficacy in the treatment of renal cell carcinoma (RCC). In the present study, the therapeutic effects of EGCG in vitro were inves...
Bewaard in:
| Gepubliceerd in: | Exp Ther Med |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4812156/ https://ncbi.nlm.nih.gov/pubmed/27073430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3050 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|